About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension

NCT00299806·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novartis

Age

20–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age: 20 - 80 years old
Gender: Male or female
Status: Outpatients
severe hypertension

You may not be if

Patients with a clinically significant allergy
Patients who have received other investigational drug
Alcoholic patients

The record

StatusCompleted

PhasePhase 3

Taking part39

StartedApr 2006

UpdatedNov 18, 2016

Conditions

Where1

Novartis Pharmaceuticals
Japan, Japan

Clareo Health | SPP100 (Aliskiren) Regimen in Patients With Severe Hypertension